Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1464
Source ID: NCT01111422
Associated Drug: N-Acetylcysteine
Title: Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: End-Stage Kidney Disease|Peritoneal Dialysis
Interventions: DRUG: N-acetylcysteine
Outcome Measures: Primary: Peritoneal membrane function, Changes in peritoneal membrane function (Δ D/Pcreatinine, ΔD/Purea) with peritoneal equilibrium test, 6 months | Secondary: Oxydative stress status, Measurement of oxydative stress status with plasma and RBC (GSH/GSSG, 8-OHdG), 6 months|Mesothelial cell transformation (Epithelial to Mesenchymal Transition), Morphology was analysed with peritoneal dialysate isolated mesothelial cell, 6 month|Residual renal function, Changes in residual renal function (ΔKt/Vurea, ΔeGFR), 6 month|Peritoneal membrane function, Changes in peritoneal membrane function (Δ D/Pcreatinine, ΔD/Purea) with peritoneal equilibrium test, 2 months
Sponsor/Collaborators: Sponsor: Ewha Womans University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 66
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-03
Completion Date: 2011-12
Results First Posted:
Last Update Posted: 2010-04-27
Locations: Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT01111422